Literature DB >> 20225282

Microemboli may link spreading depression, migraine aura, and patent foramen ovale.

Ala Nozari1, Ergin Dilekoz, Inna Sukhotinsky, Thor Stein, Katharina Eikermann-Haerter, Christina Liu, Yumei Wang, Matthew P Frosch, Christian Waeber, Cenk Ayata, Michael A Moskowitz.   

Abstract

OBJECTIVE: Patent foramen ovale and pulmonary arteriovenous shunts are associated with serious complications such as cerebral emboli, stroke, and migraine with aura. The pathophysiological mechanisms that link these conditions are unknown. We aimed to establish a mechanism linking microembolization to migraine aura in an experimental animal model.
METHODS: We introduced particulate or air microemboli into the carotid circulation in mice to determine whether transient microvascular occlusion, insufficient to cause infarcts, triggered cortical spreading depression (CSD), a propagating slow depolarization that underlies migraine aura.
RESULTS: Air microemboli reliably triggered CSD without causing infarction. Polystyrene microspheres (10 microm) or cholesterol crystals (<70 microm) triggered CSD in 16 of 28 mice, with 60% of the mice (40% of those with CSD) showing no infarcts or inflammation on detailed histological analysis of serial brain sections. No evidence of injury was detected on magnetic resonance imaging examination (9.4T; T2 weighted) in 14 of 15 selected animals. The occurrence of CSD appeared to be related to the magnitude and duration of flow reduction, with a triggering mechanism that depended on decreased brain perfusion but not sustained tissue damage.
INTERPRETATION: In a mouse model, microemboli triggered CSD, often without causing microinfarction. Paradoxical embolization then may link cardiac and extracardiac right-to-left shunts to migraine aura. If translatable to humans, a subset of migraine auras may belong to a spectrum of hypoperfusion disorders along with transient ischemic attacks and silent infarcts.

Entities:  

Mesh:

Year:  2010        PMID: 20225282      PMCID: PMC2921919          DOI: 10.1002/ana.21871

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  42 in total

1.  Spreading and synchronous depressions of cortical activity in acutely injured human brain.

Authors:  Anthony J Strong; Martin Fabricius; Martyn G Boutelle; Stuart J Hibbins; Sarah E Hopwood; Robina Jones; Mark C Parkin; Martin Lauritzen
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine.

Authors:  Martijn C Post; Vincent Thijs; Luc Herroelen; Werner I H L Budts
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

3.  Prevalence of patent foramen ovale in patients with stroke.

Authors:  P Lechat; J L Mas; G Lascault; P Loron; M Theard; M Klimczac; G Drobinski; D Thomas; Y Grosgogeat
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

4.  Focal ischaemia caused by instability of cerebrovascular tone during attacks of hemiplegic migraine. A regional cerebral blood flow study.

Authors:  L Friberg; T S Olsen; P E Roland; N A Lassen
Journal:  Brain       Date:  1987-08       Impact factor: 13.501

5.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

6.  Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons.

Authors:  P T Wilmshurst; S Nightingale; K P Walsh; W L Morrison
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

7.  Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm.

Authors:  C Lamy; C Giannesini; M Zuber; C Arquizan; J F Meder; D Trystram; J Coste; J L Mas
Journal:  Stroke       Date:  2002-03       Impact factor: 7.914

8.  Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks.

Authors:  M Schwerzmann; S Wiher; K Nedeltchev; H P Mattle; A Wahl; C Seiler; B Meier; S Windecker
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

9.  Migraine as a risk factor for subclinical brain lesions.

Authors:  Mark C Kruit; Mark A van Buchem; Paul A M Hofman; Jacobus T N Bakkers; Gisela M Terwindt; Michel D Ferrari; Lenore J Launer
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

10.  Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration.

Authors:  A R Andersen; L Friberg; T S Olsen; J Olesen
Journal:  Arch Neurol       Date:  1988-02
View more
  87 in total

1.  Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations.

Authors:  Katharina Eikermann-Haerter; Jeong Hyun Lee; Izumi Yuzawa; Christina H Liu; Zhipeng Zhou; Hwa Kyoung Shin; Yi Zheng; Tao Qin; Tobias Kurth; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

2.  Congenital heart conditions: the 'headache' of assessing a link between PFO and migraine.

Authors:  Gianluca Rigatelli
Journal:  Nat Rev Cardiol       Date:  2010-07       Impact factor: 32.419

3.  Improving migraine by means of primary transcatheter patent foramen ovale closure: long-term follow-up.

Authors:  Gianluca Rigatelli; Fabio Dell'avvocata; Paolo Cardaioli; Massimo Giordan; Gabriele Braggion; Silvio Aggio; Roberto L'erario; Mauro Chinaglia
Journal:  Am J Cardiovasc Dis       Date:  2012-05-20

Review 4.  Migraine aura pathophysiology: the role of blood vessels and microembolisation.

Authors:  Turgay Dalkara; Ala Nozari; Michael A Moskowitz
Journal:  Lancet Neurol       Date:  2010-03       Impact factor: 44.182

5.  Phospholipid-Coated Hydrophobic Mesoporous Silica Nanoparticles Enhance Thrombectomy by High-Intensity Focused Ultrasound with Low Production of Embolism-Inducing Clot Debris.

Authors:  Nicholas T Blum; Ciara M Gyorkos; Spencer J Narowetz; Evan N Mueller; Andrew P Goodwin
Journal:  ACS Appl Mater Interfaces       Date:  2019-09-26       Impact factor: 9.229

6.  [Update Stroke Conference 2011: International Stroke Conference 2011, Los Angeles, USA].

Authors:  M Ebinger; M Endres
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

7.  Migraine and cardiovascular disease in women and the role of aspirin: subgroup analyses in the Women's Health Study.

Authors:  Tobias Kurth; Hans-Christoph Diener; Julie E Buring
Journal:  Cephalalgia       Date:  2011-06-14       Impact factor: 6.292

Review 8.  The Role of Endothelin in the Pathophysiology of Migraine-a Systematic Review.

Authors:  Afrim Iljazi; Cenk Ayata; Messoud Ashina; Anders Hougaard
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

Review 9.  Cortical spreading depression and migraine.

Authors:  Andrew C Charles; Serapio M Baca
Journal:  Nat Rev Neurol       Date:  2013-09-17       Impact factor: 42.937

Review 10.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.